title: The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes.
abstract: Since infection with Helicobacter pylori has been suggested to play a pathogenic role in diabetes mellitus, we investigated whether eradication therapy for H. pylori might affect glycemic control in Japanese subjects with type 2 diabetes. A total of 72 subjects (55 males, 17 females; aged 63.7 years) with type 2 diabetes who received eradication therapy for H. pylori were included. The change of their blood glycosylated hemoglobin (A1C) levels 3 months before (-3 m) the H. pylori eradication, as well as 3 months (3 m) and 6 months (6 m) after were evaluated. Their A1C levels did not show any significant change after therapy {6.9 [0.1]% (-3 m) to 7.0 [0.1]% (3 m); P = 0.3, 7.0 [0.1] (6 m); P = 0.3}. Our findings suggest that the eradication therapy for H. pylori does not, at least profoundly, affect glycemic control in Japanese subjects with type 2 diabetes.
authors: Center for Diabetes and Endocrinology.
authors: Yoshiharu
authors: Y
authors: Wada
authors: Yoshiyuki
authors: Y
authors: Hamamoto
authors: Yukiko
authors: Y
authors: Kawasaki
authors: Sachiko
authors: S
authors: Honjo
authors: Kanta
authors: K
authors: Fujimoto
authors: Hisato
authors: H
authors: Tatsuoka
authors: Atsuko
authors: A
authors: Matsuoka
authors: Hiroki
authors: H
authors: Ikeda
authors: Jun
authors: J
authors: Fujikawa
authors: Hiroyuki
authors: H
authors: Koshiyama
keywords: diabetes; eradication; helicobacter pylori
references: Ann N Y Acad Sci. 2008 Dec;1150:208-9
references: 19120296
references: Lancet. 2009 Jul 18;374(9685):264
references: 19616723
references: Diabetes Care. 2012 Mar;35(3):520-5
references: 22279028
references: Diabetes Res Clin Pract. 1998 Feb;39(2):143-6
references: 9597384